These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2230735)

  • 1. Attenuation of wild-type yellow fever virus by passage in HeLa cells.
    Barrett AD; Monath TP; Cropp CB; Adkins JA; Ledger TN; Gould EA; Schlesinger JJ; Kinney RM; Trent DW
    J Gen Virol; 1990 Oct; 71 ( Pt 10)():2301-6. PubMed ID: 2230735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular and biological changes associated with HeLa cell attenuation of wild-type yellow fever virus.
    Dunster LM; Wang H; Ryman KD; Miller BR; Watowich SJ; Minor PD; Barrett AD
    Virology; 1999 Sep; 261(2):309-18. PubMed ID: 10497116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of envelope protein epitopes that are important in the attenuation process of wild-type yellow fever virus.
    Sil BK; Dunster LM; Ledger TN; Wills MR; Minor PD; Barrett AD
    J Virol; 1992 Jul; 66(7):4265-70. PubMed ID: 1376368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attenuation of Live-Attenuated Yellow Fever 17D Vaccine Virus Is Localized to a High-Fidelity Replication Complex.
    Davis EH; Beck AS; Strother AE; Thompson JK; Widen SG; Higgs S; Wood TG; Barrett ADT
    mBio; 2019 Oct; 10(5):. PubMed ID: 31641088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibodies distinguish between wild and vaccine strains of yellow fever virus by neutralization, hemagglutination inhibition, and immune precipitation of the virus envelope protein.
    Schlesinger JJ; Brandriss MW; Monath TP
    Virology; 1983 Feb; 125(1):8-17. PubMed ID: 6187129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of a monoclonal antibody specific for wild-type yellow fever virus to identify a wild-type antigenic variant in 17D vaccine pools.
    Gould EA; Buckley A; Cane PA; Higgs S; Cammack N
    J Gen Virol; 1989 Jul; 70 ( Pt 7)():1889-94. PubMed ID: 2472467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of monoclonal antibodies that distinguish between 17D-204 and other strains of yellow fever virus.
    Barrett AD; Mathews JH; Miller BR; Medlen AR; Ledger TN; Roehrig JT
    J Gen Virol; 1990 Jan; 71 ( Pt 1)():13-8. PubMed ID: 1689367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutation in a 17D-204 vaccine substrain-specific envelope protein epitope alters the pathogenesis of yellow fever virus in mice.
    Ryman KD; Ledger TN; Campbell GA; Watowich SJ; Barrett AD
    Virology; 1998 Apr; 244(1):59-65. PubMed ID: 9581778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of neurovirulence of different strains of yellow fever virus in mice.
    Barrett AD; Gould EA
    J Gen Virol; 1986 Apr; 67 ( Pt 4)():631-7. PubMed ID: 3958694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome Characterization of Yellow Fever Virus Wild-Type Strain Asibi, Parent to Live-Attenuated 17D Vaccine, from Three Different Sources.
    Davis EH; Thompson JK; Widen SG; Barrett ADT
    Viruses; 2021 Jul; 13(7):. PubMed ID: 34372589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Examination of the immunological relationships between flaviviruses using yellow fever virus monoclonal antibodies.
    Gould EA; Buckley A; Cammack N; Barrett AD; Clegg JC; Ishak R; Varma MG
    J Gen Virol; 1985 Jul; 66 ( Pt 7)():1369-82. PubMed ID: 2410549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the genomes of the wild-type French viscerotropic strain of yellow fever virus with its vaccine derivative French neurotropic vaccine.
    Wang E; Ryman KD; Jennings AD; Wood DJ; Taffs F; Minor PD; Sanders PG; Barrett AD
    J Gen Virol; 1995 Nov; 76 ( Pt 11)():2749-55. PubMed ID: 7595382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Yellow fever virus envelope protein has two discrete type-specific neutralizing epitopes.
    Ryman KD; Ledger TN; Weir RC; Schlesinger JJ; Barrett AD
    J Gen Virol; 1997 Jun; 78 ( Pt 6)():1353-6. PubMed ID: 9191929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutralizing F(ab')2 fragments of protective monoclonal antibodies to yellow fever virus (YF) envelope protein fail to protect mice against lethal YF encephalitis.
    Schlesinger JJ; Chapman S
    J Gen Virol; 1995 Jan; 76 ( Pt 1)():217-20. PubMed ID: 7844536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Passage of Japanese encephalitis virus in HeLa cells results in attenuation of virulence in mice.
    Cao JX; Ni H; Wills MR; Campbell GA; Sil BK; Ryman KD; Kitchen I; Barrett AD
    J Gen Virol; 1995 Nov; 76 ( Pt 11)():2757-64. PubMed ID: 7595383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccine and Wild-Type Strains of Yellow Fever Virus Engage Distinct Entry Mechanisms and Differentially Stimulate Antiviral Immune Responses.
    Fernandez-Garcia MD; Meertens L; Chazal M; Hafirassou ML; Dejarnac O; Zamborlini A; Despres P; Sauvonnet N; Arenzana-Seisdedos F; Jouvenet N; Amara A
    mBio; 2016 Feb; 7(1):e01956-15. PubMed ID: 26861019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Location of a neutralization determinant in the E protein of yellow fever virus (17D vaccine strain).
    Lobigs M; Dalgarno L; Schlesinger JJ; Weir RC
    Virology; 1987 Dec; 161(2):474-8. PubMed ID: 2446422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-Function of the Yellow Fever Virus Envelope Protein: Analysis of Antibody Epitopes.
    Davis EH; Barrett ADT
    Viral Immunol; 2020; 33(1):12-21. PubMed ID: 31682201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Examination of the envelope glycoprotein of yellow fever vaccine viruses with monoclonal antibodies.
    Barrett AD; Pryde A; Medlen AR; Ledger TN; Whitby JE; Gibson CA; DeSilva M; Groves DJ; Langley DJ; Minor PD
    Vaccine; 1989 Aug; 7(4):333-6. PubMed ID: 2479185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutralization of yellow fever virus studied using monoclonal and polyclonal antibodies.
    Buckley A; Gould EA
    J Gen Virol; 1985 Dec; 66 ( Pt 12)():2523-31. PubMed ID: 2999305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.